Dosimetric correlation of bone marrow irradiation with acute hematological toxicity in concurrent chemoradiation of cervical carcinoma patients
Open Access
- 2 August 2022
- journal article
- research article
- Published by Medknow in Indian Journal of Cancer
- Vol. 60 (3) , 432-438
Abstract
Background: Many acute toxicities are associated with concurrent chemoradiation in cervical carcinoma, which includes burning micturition, burning defecation, pain lower abdomen, increased frequency of stools along with Acute Hematological Toxicity (AHT). AHT is often an expected adverse effect, which can lead to treatment interruptions and decreased response rates. The purpose of this study is to analyze if there are any dosimetric constraints on the volume of bone marrow irradiated with AHT in cervical carcinoma patients treated with concurrent chemoradiation. Material and Methods: In this retrospective study of 215 patients, a total of 180 patients were eligible for analysis. Multiple parameters of bone marrow volumes (whole pelvis bone marrow and its sub-volumes––ilium, lower pelvis, and lumbosacral spine) which were contoured individually for all patients were assessed to have any statistically significant association with AHT. Results: The median age of the cohort was 57 years and majority of cases were locally advanced (stage IIB-IVA: 88.3%). Grade I, II, III leukopenia was seen in 44, 25, and 6 patients, respectively. A statistically significant correlation between grade 2+ and 3+ leukopenia was seen if bone marrow V10, V20, V30, and V40 were more than 95%, 82%, 62%, and 38%, respectively. In subvolume analysis, volumes of lumbosacral spine V20, V30, and V40 more than 95%, 90%, and 65%, respectively, were statistically significant for AHT. Conclusion: Bone marrow volumes should also be given a constraint and should be tried to be achieved so that it leads to minimal treatment breaks due to AHT.Keywords
This publication has 26 references indexed in Scilit:
- Radiation-Related Predictors of Hematologic Toxicity After Concurrent Chemoradiation for Cervical Cancer and Implications for Bone Marrow–Sparing Pelvic IMRTInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET ImagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Cervical Cancer Patients Treated With ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Five Years' Experience Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiotherapy and High-Dose-Rate Brachytherapy: Results From a Single InstitutionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy aloneActa Oncologica, 2004
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993